04:45 PM EDT, 06/13/2025 (MT Newswires) -- CytoMed Therapeutics ( GDTC ) filed a registration statement for the sale of $50 million of securities from time to time.
The offering includes common shares, warrants, debt securities, rights, units and share purchase contracts, the company said Friday in the filing.